Spruce Biosciences (SPRB)
(Delayed Data from NSDQ)
$0.52 USD
+0.01 (1.76%)
Updated Oct 18, 2024 03:58 PM ET
After-Market: $0.52 0.00 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.27 | 0.00% |
Earnings Summary
For their last quarter, Spruce Biosciences (SPRB) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.33 per share. This reflects a positive earnings surprise of 33.33%. Look out for SPRB's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.27 per share, reflecting a year-over-year increase of 10%.
Earnings History
Price & Consensus
Zacks News for SPRB
G1 Therapeutics (GTHX) Reports Q2 Loss, Tops Revenue Estimates
SPRB: What are Zacks experts saying now?
Zacks Private Portfolio Services